高血压病的发病率很高,常随着年龄的增长呈抛物线形上升,并易致心、脑、肾等严重并发症,故其危害性极大。由于其病因尚未完全阐明,发病机理复杂,故治疗问题仍然是当前研究的一个重要课题。近年来对下丘脑多肽激素——生长抑制素(Somatostatin,简称 SS)的分离、鉴定和人工合成的成功,为防治高血压病及其并发症的研究开辟了新的途径。由于 SS 对中枢-交感神经机制和肾素-血管紧张素-醛固酮系统 Hypertension incidence is high, often with a parabolic rise in age, and easy to cause heart, brain, kidney and other serious complications, so the great harm. Because of its etiology has not yet been fully elucidated, pathogenesis is complex, so the treatment is still an important issue in current research. In recent years, the success of isolation, identification and artificial synthesis of hypothalamic peptide hormone Somatostatin (SS) has opened up a new way for the prevention and treatment of hypertension and its complications. Due to the SS-centered-sympathetic and renin-angiotensin-aldosterone system